Gonzalez, Trevor J. http://orcid.org/0000-0002-2242-4483
Simon, Katherine E.
Blondel, Leo O. http://orcid.org/0000-0002-9211-259X
Fanous, Marco M.
Roger, Angela L. http://orcid.org/0000-0001-5249-7176
Maysonet, Maribel Santiago
Devlin, Garth W.
Smith, Timothy J.
Oh, Daniel K.
Havlik, L. Patrick
Castellanos Rivera, Ruth M.
Piedrahita, Jorge A.
ElMallah, Mai K.
Gersbach, Charles A. http://orcid.org/0000-0003-1478-4013
Asokan, Aravind http://orcid.org/0000-0001-5563-4877
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UH3AR075336)
Article History
Received: 3 March 2022
Accepted: 26 September 2022
First Online: 10 October 2022
Competing interests
: T.J.G, L.P.H., and A.A. have filed patent applications on the subject matter of this manuscript. A.A. is a co-founder at StrideBio and TorqueBio and serves on the advisory boards of Atsena Therapeutics, Isolere Bio, Mammoth Bio, Ring Therapeutics, and Kriya Therapeutics. C.A.G. is an advisor to Sarepta Therapeutics, Tune Therapeutics, Levo Therapeutics, and Iveric Bio and a co-founder of Tune Therapeutics, Element Genomics, and Locus Biosciences. R.M.C.R. and M.S.M. were employed at StideBio Inc., at this time. The remaining authors declare no competing interests.